Literature DB >> 33289452

Do you really have the only, right, or best evidence-based approach to treat your patients?

Sean P Riley1, Christopher Petrosino1, Joshua A Cleland2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33289452      PMCID: PMC7733912          DOI: 10.1080/10669817.2020.1847413

Source DB:  PubMed          Journal:  J Man Manip Ther        ISSN: 1066-9817


× No keyword cloud information.
  7 in total

1.  Myth of evidence-based practice.

Authors:  R P Di Fabio
Journal:  J Orthop Sports Phys Ther       Date:  1999-11       Impact factor: 4.751

2.  Do primary-care clinicians think that nonspecific low back pain is one condition?

Authors:  Peter Kent; Jenny Keating
Journal:  Spine (Phila Pa 1976)       Date:  2004-05-01       Impact factor: 3.468

3.  Disentangling classification systems from their individual categories and the category-specific criteria: an essential consideration to evaluate clinical utility.

Authors:  Julie Fritz
Journal:  J Man Manip Ther       Date:  2010-12

4.  Are movement-based classification systems more effective than therapeutic exercise or guideline based care in improving outcomes for patients with chronic low back pain? A systematic review.

Authors:  Sean P Riley; Brian T Swanson; Elizabeth Dyer
Journal:  J Man Manip Ther       Date:  2018-10-17

5.  Evidence - based medicine/practice in sports physical therapy.

Authors:  Robert C Manske; B J Lehecka
Journal:  Int J Sports Phys Ther       Date:  2012-10

6.  Treatment-based subgroups of low back pain: a guide to appraisal of research studies and a summary of current evidence.

Authors:  Steven J Kamper; Christopher G Maher; Mark J Hancock; Bart W Koes; Peter R Croft; Elaine Hay
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-04       Impact factor: 4.098

7.  The prognostic consequences in the making of the initial medical diagnosis of work-related back injuries.

Authors:  L Abenhaim; M Rossignol; D Gobeille; Y Bonvalot; P Fines; S Scott
Journal:  Spine (Phila Pa 1976)       Date:  1995-04-01       Impact factor: 3.468

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.